4 reports

gastrointestinal involvement.

  • Lung Transplant
  • Transplantation
  • United States
  • Product Initiative
  • Kamada Ltd.

As of February 2012, the drug candidate was in Phase I/ II stage of development for Other Gastrointestinal Disorders.

  • Lung Transplant
  • United States
  • World
  • Product Initiative
  • Kamada Ltd.
  • Clinical Trial profile. 7 Trial Title
  • Clinical Trial Profile Snapshots

Gastrointestinal Tolerability of Mycophenolate Mofetil (MMF, Cellcept) and Enteric-coated Mycophenolate Sodium (EC-MPS, Myfortic) in Maintenance Transplant Patients Treated with Calcineurin Inhibitors Gastrointestinal Tolerability of MMF vs EC-MPS in Maintenance Transplant Patients

  • Lung Transplant
  • Transplantation
  • World
  • Product Initiative
  • Novartis AG

As of January 2011, the drug candidate was Phase I/ II for gastrointestinal stromal tumor (GIST), chronic myelocytic leukemia (CML) and Phase II stage of development for age related macular degeneration.

  • Lung Transplant
  • Therapy
  • Transplantation
  • United States
  • Product Initiative